Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pharmacy costs of specialty medications for plaque psoriasis in the United States  Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

Published byDewi Hartono Modified over 6 years ago

Similar presentations

Presentation on theme: "Pharmacy costs of specialty medications for plaque psoriasis in the United States  Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,"— Presentation transcript:

1 Pharmacy costs of specialty medications for plaque psoriasis in the United States 
Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani, MD  Journal of the American Academy of Dermatology  Volume 80, Issue 1, Pages (January 2019) DOI: /j.jaad Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Trends in the costs of the first year of treatment per patient for specialty medications for plaque psoriasis from November 28, 2013, to October 4, 2017. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

Download ppt "Pharmacy costs of specialty medications for plaque psoriasis in the United States  Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,"

Similar presentations

Treatment of generalized lichen nitidus with narrowband ultraviolet B Jae-Hong Park, MD, Yun-Lim Choi, MD, Won-Serk Kim, MD, Dong-Youn Lee, MD, Jun-Mo.

Treatment of generalized lichen nitidus with narrowband ultraviolet B Jae-Hong Park, MD, Yun-Lim Choi, MD, Won-Serk Kim, MD, Dong-Youn Lee, MD, Jun-Mo.
Localized bullous fixed drug eruption following yellow fever vaccine

Localized bullous fixed drug eruption following yellow fever vaccine
Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses  Michael Abrouk, BS, Benjamin Farahnik, BS, Tian Hao Zhu, BS, Mio Nakamura,

Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses  Michael Abrouk, BS, Benjamin Farahnik, BS, Tian Hao Zhu, BS, Mio Nakamura,
Tsung-Yu Tsai, MD, Yu-Chen Huang, MD 

Tsung-Yu Tsai, MD, Yu-Chen Huang, MD 
Acute transverse myelitis during treatment with etanercept for severe plaque psoriasis  Juan Escalas, PhD, MD, Nicole Knöpfel, MD, Ana Martin-Santiago,

Acute transverse myelitis during treatment with etanercept for severe plaque psoriasis  Juan Escalas, PhD, MD, Nicole Knöpfel, MD, Ana Martin-Santiago,
Facial adenocarcinoma treated with intra-arterial chemotherapy

Facial adenocarcinoma treated with intra-arterial chemotherapy
Volume 3, Issue 6, Pages (November 2017)

Volume 3, Issue 6, Pages (November 2017)
Yul W. Yang, MD, PhD, David J. DiCaudo, MD 

Yul W. Yang, MD, PhD, David J. DiCaudo, MD 
Successful treatment of lipoatrophy with normal saline

Successful treatment of lipoatrophy with normal saline
Psoriasis: Latitude does make a difference

Psoriasis: Latitude does make a difference
Baldness reversed by chemotherapy

Baldness reversed by chemotherapy
Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD 

Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD 
CME examination Journal of the American Academy of Dermatology

CME examination Journal of the American Academy of Dermatology
Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD 
Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J

Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J
The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study  Hsien-Yi Chiu, MD, Tsen-Fang.

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study  Hsien-Yi Chiu, MD, Tsen-Fang.
Pediatric teledermatology: Observations based on 429 consults

Pediatric teledermatology: Observations based on 429 consults
Ana Corcimaru, BS, Dean S. Morrell, MD, Craig N. Burkhart, MD 

Ana Corcimaru, BS, Dean S. Morrell, MD, Craig N. Burkhart, MD 
Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD 

Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD 
Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting  Marisa.

Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting  Marisa.

Similar presentations

Ads by Google